Picture of Strategic Partners A/S logo

STRAP — Strategic Partners A/S Share Price

0.000.00%
dk flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-16.22%
3m-18.13%
6m-14.95%
1yr-42.64%
Volume Change (%)
10d/3m+12.68%
Price vs... (%)
52w High-33.52%
50d MA-10.88%
200d MA-12.53%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-10.21%
Return on Equity7.19%
Operating Margin-484.6%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Strategic Partners A/S EPS forecast chart

Profile Summary

Strategic Partners A/S, formerly Orphazyme A/S, is a Denmark-based company active within the biopharmaceutical industry. It develops new therapies for the treatment of a family of genetic disorders. The Company's main focus is on preclinical development of medicines for the treatment of lysosomal storage diseases (LSDs), a group of approximately 50 genetic disorders that result from deficiencies of lysosomal enzymes or other lysosomal components, and protein aggregation diseases. The Company’s candidate, arimoclomol, stimulates the production of the cells’ protein rescue system, the heat shock proteins, which helps the misfolded proteins to either get back to their functional shape or, if this cannot be achieved, remove them from the cells by means of the cells’ recycling system, the lysosomes, so they no longer form toxic aggregates. The Company collaborates with academic institutions in Europe and the United States.

Directors

    Last Annual
    December 31st, 2025
    Last Interim
    June 30th, 2026
    Incorporated
    June 19th, 2009
    Public Since
    November 17th, 2017
    No. of Employees
    1
    Sector
    Investment Banking & Investment Services
    Industry
    Financials
    Exchange
    dk flag iconOMX Nordic Exchange - Copenhagen
    Shares in Issue
    54,112
    Blurred out image of a map
    Address
    Lyskaer 8A, HERLEV, 2730
    Web
    https://www.strategic-partners.dk/
    Phone
    Auditors
    BDO Statsautoriseret Revisionsaktieselskab

    STRAP Share Price Performance

    Upcoming Events for STRAP

    Q3 2026 Strategic Partners A/S Earnings Release

    Strategic Partners A/S Annual Shareholders Meeting

    Similar to STRAP

    Picture of Investeringsselskabet Luxor A/S logo

    Investeringsselskabet Luxor A/S

    dk flag iconOMX Nordic Exchange - Copenhagen

    Picture of Newcap Holding A/S logo

    Newcap Holding A/S

    dk flag iconOMX Nordic Exchange - Copenhagen

    FAQ